Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Feb 28, 2017 | $30.9B |
| FY2017, ended Feb 28, 2018 | $41.2B |
| FY2018, ended Feb 28, 2019 | $32.4B |
| FY2019, ended Feb 29, 2020 | $33.2B |
| FY2020, ended Feb 28, 2021 | $41.5B |
| FY2021, ended Feb 28, 2022 | $40.6B |
| FY2022, ended Feb 28, 2023 | $41.0B |
| FY2023, ended Feb 29, 2024 | $45.5B |
| FY2024, ended Feb 28, 2025 | $31.2B |
| FY2025, ended Feb 28, 2026 | $27.2B |
| Trailing 12 months to Aug 31, 2026 (through Q2 FY2026) | $22.1B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Feb 28, 2017 | $8.06B |
| FY2017, ended Feb 28, 2018 | $8.33B |
| FY2018, ended Feb 28, 2019 | $8.88B |
| FY2019, ended Feb 29, 2020 | $9.11B |
| FY2020, ended Feb 28, 2021 | $9.36B |
| FY2021, ended Feb 28, 2022 | $9.53B |
| FY2022, ended Feb 28, 2023 | $10.2B |
| FY2023, ended Feb 29, 2024 | $10.7B |
| FY2024, ended Feb 28, 2025 | $11.0B |
| FY2025, ended Feb 28, 2026 | $9.76B |
| Trailing 12 months to Aug 31, 2026 (through Q2 FY2026) | $9.83B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Feb 28, 2017 | $1.53B | $789M |
| FY2017, ended Feb 28, 2018 | $2.30B | $874M |
| FY2018, ended Feb 28, 2019 | $3.44B | $1.36B |
| FY2019, ended Feb 29, 2020 | −$11.8M | $1.82B |
| FY2020, ended Feb 28, 2021 | $2.00B | $1.94B |
| FY2021, ended Feb 28, 2022 | −$40.4M | $1.68B |
| FY2022, ended Feb 28, 2023 | −$71.0M | $1.72B |
| FY2023, ended Feb 29, 2024 | $1.73B | $1.51B |
| FY2024, ended Feb 28, 2025 | −$81.4M | $1.94B |
| FY2025, ended Feb 28, 2026 | $1.69B | $1.79B |
| Trailing 12 months to Aug 31, 2026 (through Q2 FY2026) | $1.92B | $1.84B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Feb 28, 2017 | $177M |
| FY2017, ended Feb 28, 2018 | $90.3M |
| FY2018, ended Feb 28, 2019 | $93.6M |
| FY2019, ended Feb 29, 2020 | $81.4M |
| FY2020, ended Feb 28, 2021 | $461M |
| FY2021, ended Feb 28, 2022 | $199M |
| FY2022, ended Feb 28, 2023 | $134M |
| FY2023, ended Feb 29, 2024 | $152M |
| FY2024, ended Feb 28, 2025 | $68.1M |
| FY2025, ended Feb 28, 2026 | $102M |
| Trailing 12 months to Aug 31, 2026 (through Q2 FY2026) | $98.5M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Feb 28, 2017 | $9.24B |
| FY2017, ended Feb 28, 2018 | $10.2B |
| FY2018, ended Feb 28, 2019 | $13.6B |
| FY2019, ended Feb 29, 2020 | $12.2B |
| FY2020, ended Feb 28, 2021 | $10.4B |
| FY2021, ended Feb 28, 2022 | $10.4B |
| FY2022, ended Feb 28, 2023 | $12.5B |
| FY2023, ended Feb 29, 2024 | $11.9B |
| FY2024, ended Feb 28, 2025 | $11.5B |
| FY2025, ended Feb 28, 2026 | $10.6B |
| Trailing 12 months to Aug 31, 2026 (through Q2 FY2026) | $10.3B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 13.1% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Feb 28, 2017 | 195M |
| FY2017, ended Feb 28, 2018 | 191M |
| FY2018, ended Feb 28, 2019 | 191M |
| FY2019, ended Feb 29, 2020 | 193M |
| FY2020, ended Feb 28, 2021 | 194M |
| FY2021, ended Feb 28, 2022 | 188M |
| FY2022, ended Feb 28, 2023 | 183M |
| FY2023, ended Feb 29, 2024 | 183M |
| FY2024, ended Feb 28, 2025 | 178M |
| FY2025, ended Feb 28, 2026 | 172M |
| Trailing 12 months to Aug 31, 2026 (through Q2 FY2026) | 169M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Feb 28, 2017 | $1.12B | $56.1M |
| FY2017, ended Feb 28, 2018 | $1.04B | $60.9M |
| FY2018, ended Feb 28, 2019 | $504M | $64.1M |
| FY2019, ended Feb 29, 2020 | $50.0M | $60.4M |
| FY2020, ended Feb 28, 2021 | $0 | $63.0M |
| FY2021, ended Feb 28, 2022 | $1.39B | $44.9M |
| FY2022, ended Feb 28, 2023 | $1.70B | $68.5M |
| FY2023, ended Feb 29, 2024 | $250M | $63.6M |
| FY2024, ended Feb 28, 2025 | $1.12B | $72.2M |
| FY2025, ended Feb 28, 2026 | $924M | $67.7M |
| Trailing 12 months to Aug 31, 2026 (through Q2 FY2026) | $775M | $70.5M |
Valuation
At current price- Market Cap
- $22.1B
- P/E
- 11.5×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 2.2×
- Price / Book
- 2.6×
- EV / EBITDA
- 10.1×
Growth
Trailing 12 months- Revenue (TTM)
- $9.83B
- Revenue Growth YoY
- −4.4%
- Revenue CAGR 3Y
- −1.4%
- Revenue CAGR 5Y
- 0.8%
- EPS Growth YoY
- —. Diluted EPS, TTM vs. TTM a year earlier
- Net Income Growth YoY
- 57.4%
Profitability
Trailing 12 months- Gross Margin
- 49.3%
- Operating Margin
- 28.3%
- Net Margin
- 19.6%
- FCF Margin
- 18.7%
- Return on Equity
- 23.9%
Earnings
Trailing 12 months- Net Income
- $1.92B
- EPS (diluted)
- —
- EBITDA
- $3.19B
- Operating Income
- $2.78B
Balance Sheet
As of Aug 31, 2026- Cash and cash equivalents
- $98.5M
- Total Debt
- $10.3B
- Net Debt
- $10.2B
- Total Assets
- $22.1B
- Total Liabilities
- $13.2B
- Shareholders' Equity
- $8.59B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $2.66B
- Capital Expenditure
- $819M
- Free Cash Flow
- $1.84B
Dividends and risk
Last 12 months- Dividend Yield
- 3.1%
- Dividend / Share
- $4.10
- Beta (5Y)
- 0.44
Every ratio is calculated from the company’s reported figures.